Relationship between DNA-reactivity and cytostatic effect of two novel bile acid-platinum derivatives, Bamet-UD2 and Bamet-D3

Anticancer Research

Volumn 20, Issue 5, 2000, Pages 3315-3321

  Martinez Diez, M C ^a   Larena, M G ^a   Serrano, M A ^a   Macias, R I R ^a   Izco Basurko, I ^a   Marin, J J G ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cancer; Chemotherapy; Cholic acid; Cisplatin; Tumour; Ursodeoxycholic acid

Indexed keywords

BAMET D3; BAMET UD2; BILE ACID; CELL DNA; CISDIAMMINE BISURSODEOXYCHOLIC PLATINUM; CISDICHLORIDE N (N' AMMINEPROPYLAMMINEPROPYL)GLYCOCHOLAMIDE PLATINUM; CISPLATIN; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CYTOSTASIS; DRUG DNA BINDING; LEUKEMIA CELL; LEUKEMIA L 1210; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; BILE ACIDS AND SALTS; CELL DIVISION; CISPLATIN; DNA; ETHIDIUM; FLUORESCENT DYES; GLYCOCHOLIC ACID; MICE; MOLECULAR STRUCTURE; ORGANOPLATINUM COMPOUNDS; TUMOR CELLS, CULTURED; URSODEOXYCHOLIC ACID;

EID: 0033794112     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diagnosis and treatment. Drugs five years later. Cisplatin
2. Platinum compounds: A new class of potent antitumour agents
3. Cisplatin nephrotoxicity
4. Characteristics of clinical and experimental resistance to cisplatin
5. Molecular basis of cisplatin resistance in human carcinomas - Model systems and patients
6. Resistance to cisplatin. How to deal with the problem?
7. Targeting chemotherapy for hepatoma- Arterial administration of anticancer drugs dissolved in lipiodol
8. Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: Physiological basis and pathophysiological changes in cholestatic liver dysfunction
9. Hepatobiliary delivery of polyaminopolycarboxylate chelates: Synthesis and characterization of a cholic acid conjugate of EDTA and biodistribution and imaging studies with its indium-111 chelate
10. Utilizing bile acid carrier mechanism to enhance liver and small intestine absorption
11. Liver-specific drug targeting by coupling to bile acids
12. Bile acid derived HMG-CoA reductase inibitors
13. Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver-targeting with cholic acid
14. Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity
15. Synthesis and characterization of the new cytostatic complex cis-diammineplatinum(II) chlorocholylglycinate. Cytostatic activity
16. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle
17. The coordination chemistry of platinum anticancer drugs and related compounds with DNA
18. In vitro cytostatic activity and DNA-interaction of the new liver organotropic complex chloro-bis-cholylglycinate-platinum (II)
19. DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2
20. New cis-diamminebis-cholylglycinate(O,O') Pt(II) and cis-diamminebis -ursodeoxycholate(O,O') Pt(II) complexes. Structural characterization, kinetic studies and biological activity
21. Synthesis, characterization, and DNA binding studies of some mixed-ligand platinum(II) complexes of 1,10-phenanthroline and amino acids
22. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function - Mini-review
23. Electrophoretic separation of polyoma virus DNA from host cell DNA
24. Electrophoresis of DNA in agarose gels. Optimizing separations of conformational isomers of double-and-single-stranded DNAs
25. Interaction of cis-dichlorodiammineplatinum(II) with DNA
26. Binding of the antitumor drug cisdiamminedichloroplatinum (II) (cisplatin) to DNA